Published in Lasers Med Sci on September 29, 2012
Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res (2007) 6.76
The clinical spectrum of Actinomyces-associated lesions of the oral mucosa and jawbones: correlations with histomorphometric analysis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2009) 1.75
Bisphosphonate-related osteonecrosis of the jaw: the role of actinomyces. Clin Infect Dis (2009) 1.59
Identification of microbial biofilms in osteonecrosis of the jaws secondary to bisphosphonate therapy. J Oral Maxillofac Surg (2008) 1.32
Actinomyces--gathering evidence of human colonization and infection. Anaerobe (2007) 1.31
Myofibroblasts in healing laser excision wounds. Lasers Surg Med (2001) 1.23
Actinomycosis of the jaws--histopathological study of 45 patients shows significant involvement in bisphosphonate-associated osteonecrosis and infected osteoradionecrosis. Virchows Arch (2007) 1.14
Nd:YAG laser biostimulation in the treatment of bisphosphonate-associated osteonecrosis of the jaw: clinical experience in 28 cases. Photomed Laser Surg (2008) 1.09
Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ) therapy. A critical review. Minerva Stomatol (2010) 1.06
Nonexposed bisphosphonate-related osteonecrosis of the jaws: another clinical variant? J Oral Maxillofac Surg (2008) 1.02
Bactericidal effect of Nd:YAG laser irradiation on some endodontic pathogens ex vivo. Int Endod J (2006) 0.98
Antibacterial effects of Nd:YAG laser irradiation within root canal dentin. J Clin Laser Med Surg (1997) 0.96
A scanning electron microscopic evaluation of in vitro dentinal tubules penetration by selected anaerobic bacteria. J Endod (1996) 0.95
Effectiveness of different laser systems to kill Enterococcus faecalis in aqueous suspension and in an infected tooth model. Int Endod J (2009) 0.94
Effects of Nd:YAG and CO2 laser treatment and ultrasonic scaling on periodontal pockets of chronic periodontitis patients. J Periodontol (2003) 0.93
A preliminary study on the effects of the Nd:YAG laser on root surfaces and subgingival microflora in vivo. J Periodontol (1992) 0.93
Bactericidal effect of the Nd:YAG laser in in vitro root canals. J Clin Laser Med Surg (1996) 0.92
Study of the direct bactericidal effect of Nd:YAG and diode laser parameters used in endodontics on pigmented and nonpigmented bacteria. Lasers Med Sci (2010) 0.90
Thermal increase in the oral mucosa and in the jawbone during Nd:YAG laser applications. Ex vivo study. Med Oral Patol Oral Cir Bucal (2012) 0.90
Bactericidal effect of a Nd:YAG laser on Enterococcus faecalis at pulse durations of 15 and 25 ms in dentine depths of 500 and 1,000 μm. Lasers Med Sci (2010) 0.84
Bacteremia following laser and conventional surgery in hamsters. J Oral Maxillofac Surg (1990) 0.83
An evaluation of the Nd:YAG laser in periodontal pocket therapy. Br Dent J (1996) 0.81
Antibacterial effects of pulsed Nd:YAG laser radiation at different energy settings in root canals. J Endod (2002) 0.81
Bactericidal effect of pulsed 1,064 nm Nd:YAG laser light on Staphylococcus epidermidis is of photothermal origin: an in vitro study. Lasers Surg Med (2000) 0.81
Infected osteoradionecrosis of the mandible: follow-up study suggests deterioration in outcome for patients with Actinomyces-positive bone biopsies. Int J Oral Maxillofac Surg (2006) 0.80
Midfacial osteomyelitis in a chronic cocaine abuser: a case report. Ear Nose Throat J (2001) 0.79
Inactivation of bacteria and yeasts on agar surfaces with high power Nd:YAG laser light. Lett Appl Microbiol (1996) 0.78
Bacteriologic evaluation of the effect of Nd:YAG laser irradiation in experimental infected root canals. J Endod (2002) 0.78
Actinomyces israelii in osteoradionecrosis of the jaws. Histopathologic and immunocytochemical study of five cases. Oral Surg Oral Med Oral Pathol (1983) 0.78
The bactericidal effect of a Genius Nd:YAG laser. Int J Dent Hyg (2010) 0.77
A novel glyco-conjugate vaccine against fungal pathogens. J Exp Med (2005) 2.35
Quantic molecular resonance scalpel and its potential applications in oral surgery. Br J Oral Maxillofac Surg (2008) 1.48
A monoclonal antibody directed against a Candida albicans cell wall mannoprotein exerts three anti-C. albicans activities. Infect Immun (2003) 1.37
Nd:YAG laser versus traditional scalpel. A preliminary histological analysis of specimens from the human oral mucosa. Lasers Med Sci (2010) 1.20
Nonexposed variant of bisphosphonate-associated osteonecrosis of the jaw: a case series. Am J Med (2010) 1.20
Bone necrosis of the jaws associated with bisphosphonate treatment: a report of twenty-nine cases. Acta Biomed (2006) 1.16
Bisphosphonates-related osteonecrosis of the jaws: a concise review of the literature and a report of a single-centre experience with 151 patients. J Oral Pathol Med (2011) 1.11
Nd:YAG laser biostimulation in the treatment of bisphosphonate-associated osteonecrosis of the jaw: clinical experience in 28 cases. Photomed Laser Surg (2008) 1.09
Interplay between protective and inhibitory antibodies dictates the outcome of experimentally disseminated Candidiasis in recipients of a Candida albicans vaccine. Infect Immun (2002) 1.08
Conformation-sensitive antibodies against alzheimer amyloid-beta by immunization with a thioredoxin-constrained B-cell epitope peptide. J Biol Chem (2007) 1.08
Er:YAG laser cavity preparation and composite resin bonding with a single-component adhesive system: relationship between shear bond strength and microleakage. Lasers Surg Med (2006) 1.06
Effects of low-level laser therapy on proliferation and differentiation of murine bone marrow cells into osteoblasts and osteoclasts. Lasers Surg Med (2009) 1.01
Surgery-triggered and non surgery-triggered Bisphosphonate-related Osteonecrosis of the Jaws (BRONJ): A retrospective analysis of 567 cases in an Italian multicenter study. Oral Oncol (2011) 1.01
Antibody complementarity-determining regions (CDRs) can display differential antimicrobial, antiviral and antitumor activities. PLoS One (2008) 1.00
Surgical approach with Er:YAG laser on osteonecrosis of the jaws (ONJ) in patients under bisphosphonate therapy (BPT). Lasers Med Sci (2009) 0.99
Antibody complementarity-determining regions (CDRs): a bridge between adaptive and innate immunity. PLoS One (2009) 0.99
Oral lichen planus pathogenesis: A role for the HCV-specific cellular immune response. Hepatology (2002) 0.98
Therapeutic activity of an engineered synthetic killer antiidiotypic antibody fragment against experimental mucosal and systemic candidiasis. Infect Immun (2003) 0.98
Welding in the dental office by fiber-delivered laser: a new technique. Photomed Laser Surg (2009) 0.95
Protection of killer antiidiotypic antibodies against early invasive aspergillosis in a murine model of allogeneic T-cell-depleted bone marrow transplantation. Infect Immun (2002) 0.94
Nd:YAG laser biostimulation of bisphosphonate-associated necrosis of the jawbone with and without surgical treatment. Br J Oral Maxillofac Surg (2007) 0.93
Case series of 589 tooth extractions in patients under bisphosphonates therapy. Proposal of a clinical protocol supported by Nd:YAG low-level laser therapy. Med Oral Patol Oral Cir Bucal (2013) 0.92
Laser-assisted surgery with different wavelengths: a preliminary ex vivo study on thermal increase and histological evaluation. Lasers Med Sci (2012) 0.92
Involvement of [beta]-glucans in the wide-spectrum antimicrobial activity of Williopsis saturnus var. mrakii MUCL 41968 killer toxin. Mol Med (2002) 0.90
In vitro acanthamoebicidal activity of a killer monoclonal antibody and a synthetic peptide. J Antimicrob Chemother (2006) 0.90
Scanning electron microscopic evaluation of resin-dentin interface after Er:YAG laser preparation. Lasers Surg Med (2004) 0.90
Thermal increase in the oral mucosa and in the jawbone during Nd:YAG laser applications. Ex vivo study. Med Oral Patol Oral Cir Bucal (2012) 0.90
Activity of an engineered synthetic killer peptide on Leishmania major and Leishmania infantum promastigotes. Exp Parasitol (2006) 0.89
Oral postinflammatory pigmentation: an analysis of 7 cases. Med Oral Patol Oral Cir Bucal (2011) 0.89
β-Actin-binding complementarity-determining region 2 of variable heavy chain from monoclonal antibody C7 induces apoptosis in several human tumor cells and is protective against metastatic melanoma. J Biol Chem (2012) 0.89
Intraoral laser welding: ultrastructural and mechanical analysis to compare laboratory laser and dental laser. Lasers Med Sci (2010) 0.88
Intraoral metal laser welding: a case report. Lasers Med Sci (2009) 0.88
Differential Antitumor Effects of IgG and IgM Monoclonal Antibodies and Their Synthetic Complementarity-Determining Regions Directed to New Targets of B16F10-Nex2 Melanoma Cells. Transl Oncol (2010) 0.87
Shear bond strength of self-etching adhesive systems to Er:YAG laser-prepared dentine with and without pulpal pressure simulation. Photomed Laser Surg (2008) 0.87
Bisphosphonate-associated osteonecrosis (BON) of the jaws: a possible treatment? J Oral Maxillofac Surg (2006) 0.87
Morpho-structural aspects of Er:YAG-prepared class V cavities. J Clin Laser Med Surg (2004) 0.86
A synthetic peptide as a novel anticryptococcal agent. Cell Microbiol (2004) 0.86
Microleakage of resin-based sealants after Er:YAG laser conditioning. Lasers Med Sci (2007) 0.86
Early surgical laser-assisted management of bisphosphonate-related osteonecrosis of the jaws (BRONJ): a retrospective analysis of 101 treated sites with long-term follow-up. Photomed Laser Surg (2011) 0.85
A killer mimotope with therapeutic activity against AIDS-related opportunistic micro-organisms inhibits ex-vivo HIV-1 replication. AIDS (2006) 0.85
Peptides of the constant region of antibodies display fungicidal activity. PLoS One (2012) 0.85
Antibody constant region peptides can display immunomodulatory activity through activation of the Dectin-1 signalling pathway. PLoS One (2012) 0.84
Reversible self-assembly: a key feature for a new class of autodelivering therapeutic peptides. Mol Pharm (2009) 0.84
Therapeutic activity of a killer peptide against experimental paracoccidioidomycosis. J Antimicrob Chemother (2004) 0.84
Anti-beta-glucan-like immunoprotective candidacidal antiidiotypic antibodies. Front Biosci (2008) 0.84